Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Leveraging the power of the IQVIA CORE, we support Canada’s pharmaceutical manufacturers as they invest in, and advance, human health. We do this via breakthroughs in insights, technology, analytics and human intelligence that bring the progress in data science together with the possibilities of human science.
Learn More
Hospitals and healthcare providers are looking for cutting-edge decision support to augment their strategy and performance so they can focus on delivering high quality value to patients. As the Human Data Science Company, IQVIA is uniquely positioned to provide actionable data, innovative technology, and expertise customized to the hospital and provider community.
Learn MoreA specialized division of IQVIA (Canada), Health Industry Information Services (HIIS) serves the precise needs of non-pharmaceutical healthcare stakeholders including Retail Pharmacy, Independent Pharmacy, and Specialty Pharmacy.
Learn More
Almost everything we do is powered by the IQVIA CORE. This holistic approach allows us to use Human Data Science to create integrated solutions for our customers.
Learn More
Health benefit analytics for effective response to market changes.
Learn More
Take your research further. Data assets that allow you to explore new areas in inquiry that can advance public health efforts. IQVIA supports the Canadian research community and has responded to hundreds of requests to support new areas of inquiry.
Learn MoreExplore our library of resources spanning the healthcare ecosystem. Hear from IQVIA data scientists, doctors, researchers, and other experts on the topics, trends, and market developments that matter to you.
Learn MoreMedia representatives and other industry stakeholders can access current and historical top-line Canada and global pharmaceutical trends for use in story development or vital health research.
Learn More
The IQVIA team will work with you to understand your business and market access strategy and ensure the reimbursement ‘ask’ aligns with the overall objectives the organization wants to achieve.
We will leverage our core strengths including broad data assets to develop evidence-based and data-driven approaches to give you the critical insights you need to refine your strategy.
With access to our global Centres of Excellence, your studies will use the most innovative methodologies while ensuring robustness of the analyses.
Optimal Reimbursement: IQVIA will directly connect with payers, medical professional and HTA to understand how your therapy is likely to be evaluated and challenges it will face.
Payer Dynamics: With data at its core, IQVIA taps its wealth of data assets to help you understand exactly how payers are evaluating reimbursement therapies, what’s driving their costs and more, to help as you develop market access and communication strategies with payers.
Maximize the Value of Therapy to Payers: IQVIA understands that a positive HTA recommendation is critical in facilitating negotiations and obtaining optimal listing for your product and we will work with you to ensure that your product’s clinical and economic value proposition is maximized.
Disseminate Your Insights: IQVIA will work closely with you to develop content that is scientifically relevant, adds to the overall body of knowledge and is disseminated through the most appropriate channels.
Learn more about how to build a consistent and compelling value story to meet HTA and payer needs.
Published expertise across therapy areas and methodologies.
